acetylcysteine has been researched along with Carcinoma, Transitional Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esuvaranathan, K; Mahendran, R; Pook, SH | 1 |
| Bicknell, R; Cranston, D; Fuggle, S; Fujiyama, C; Harris, AL; Jones, A | 1 |
| Chester, JF; Gaissert, HA; Malt, RA; Ross, JS; Weitzman, SA | 1 |
3 other study(ies) available for acetylcysteine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells.
Topics: Acetylcysteine; BCG Vaccine; Carcinoma, Transitional Cell; Cell Survival; Dexfenfluramine; Drug Synergism; Glutathione Reductase; Humans; Nitric Oxide; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion.
Topics: Acetylcysteine; Administration, Intravesical; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Differentiation; Cell Division; Disease Models, Animal; Drug Screening Assays, Antitumor; Epithelium; Humans; Neoplasm Invasiveness; Phenotype; Rats; Rats, Sprague-Dawley; Suramin; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Urokinase-Type Plasminogen Activator | 2001 |
N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder cancer in mice: augmentation by sutures through the bladder wall.
Topics: Acetylcysteine; Animals; Carcinoma, Transitional Cell; Cocarcinogenesis; Cystitis; FANFT; Female; Mice; Sutures; Urinary Bladder Neoplasms | 1987 |